https://investingnews.com/news/pharmaceutical-investing/merck-announces-clinical-holds-on-studies-evaluating-islatravir-for-the-treatment-and-prevention-of-hiv-1-infection/
Merck Announces Clinical Holds on Studies Evaluating Islatravir for the Treatment and Prevention of...
Mar 19, 2024 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has placed clinical...
https://www.mdpi.com/1999-4915/13/8/1566
Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major...
Islatravir (MK-8591) is a nucleoside reverse transcriptase translocation inhibitor in development for the treatment and prevention of HIV-1. The potential for...
https://www.merck.com/news/merck-opens-enrollment-in-new-phase-3-clinical-trials-with-investigational-once-daily-islatravir-in-combination-with-doravirine-for-treatment-of-hiv-1-infection/
Merck Opens Enrollment in New Phase 3 Clinical Trials with Investigational Once-Daily Islatravir in...
Apr 17, 2026 - Islatravir and other HIV data presented at CROI 2023 Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the company...
https://www.rti.org/publication/pharmacokinetic-study-islatravir-etonogestrel-implants-macaques
Pharmacokinetic study of Islatravir and Etonogestrel implants in Macaques | RTI
The prevention of HIV and unintended pregnancies is a public health priority. Multi-purpose prevention technologies capable of long-acting HIV and pregnancy...
pharmacokineticstudyislatraviretonogestrelimplants
https://www.merck.com/news/merck-announces-clinical-holds-on-studies-evaluating-islatravir-for-the-treatment-and-prevention-of-hiv-1-infection/
Merck Announces Clinical Holds on Studies Evaluating Islatravir for the Treatment and Prevention of...
Apr 17, 2026 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has placed clinical...
https://www.merck.com/news/merck-advances-phase-3-trial-to-evaluate-investigational-islatravir-as-once-monthly-oral-prep-for-women-at-high-risk-for-acquiring-hiv-1/
Merck Advances Phase 3 Trial to Evaluate Investigational Islatravir as Once-Monthly Oral PrEP for...
https://www.royalpharms.com/
Glecaprevir, Pibrentasvir, Insulin Degludec, Lenacapavir Sodium, Islatravir, Semaglutide,...
Jinlan Pharm-Drugs Technology Co., Limited (with its export company Hangzhou Royall Import and Export Co., Ltd.) is located in Hangzhou. ROYAL PHARM is mainly...
glecaprevir pibrentasvirinsulin degludeclenacapavir sodiumislatravirsemaglutide
https://www.merck.com/news/merck-announces-week-96-data-from-phase-2b-study-evaluating-islatravir-in-combination-with-doravirine-in-adults-with-hiv-1-infection/
Merck Announces Week 96 Data from Phase 2b Study Evaluating Islatravir in Combination With...
Apr 28, 2026 - Treatment With Islatravir and Doravirine Maintained Viral Suppression and No Viral Resistance was Identified Company Also Presenting Phase 1/1b Results for...